No abstract available
MeSH terms
-
Antineoplastic Agents / therapeutic use
-
Carcinoma, Transitional Cell / mortality
-
Carcinoma, Transitional Cell / pathology*
-
Carcinoma, Transitional Cell / therapy*
-
Combined Modality Therapy
-
Cystectomy / methods
-
Female
-
Humans
-
Male
-
Neoadjuvant Therapy*
-
Neoplasm Invasiveness / pathology*
-
Prognosis
-
Randomized Controlled Trials as Topic
-
Risk Assessment
-
Survival Analysis
-
Treatment Outcome
-
Urinary Bladder Neoplasms / mortality
-
Urinary Bladder Neoplasms / pathology*
-
Urinary Bladder Neoplasms / therapy*